🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Paraplatin®

Found 308 matching trials

A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas

PHASE1

This is a pilot clinical trial investigating the addition of haploidentical...

Status

Completed

Location

St. Jude Children's Research Hospital

Start Date

2014-10-10

Trial ID

NCT02130869

Treatments Being Tested

CD133+ selected autologous stem cell infusion IL-2 hu14.18K322A Busulfan Melphalan GM-CSF Bendamustine Etoposide Cytarabine Carboplatin Haploidentical natural killer cell infusion G-CSF Etoposide phosphate CliniMACS

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

PHASE1

Doctors leading this study hope to learn about the safety and effectiveness...

Status

Active Not Recruiting

Location

University of Chicago

Start Date

2022-08-22

Trial ID

NCT05108870

Treatments Being Tested

HB-201 HB-202 Carboplatin Paclitaxel Transoral Robotic Surgery

Study of Paclitaxel in Patients With Ovarian Cancer

PHASE3

RATIONALE: Paclitaxel is one of the most widely used human anticancer agent...

Status

Completed

Location

Gomel Regional Clincial Oncology Center

Start Date

2009-02

Trial ID

NCT00989131

Treatments Being Tested

Paclical®Taxol®

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

PHASE3

This is a Phase IIIb, multinational, multicenter, randomized, open-label st...

Status

Completed

Location

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Start Date

2022-07-05

Trial ID

NCT05415215

Treatments Being Tested

Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)Pertuzumab IV Trastuzumab IV Trastuzumab Emtansine Investigator's Choice of Chemotherapy Surgery Radiotherapy

Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)

PHASE3

This is a study to assess the efficacy and safety of pembrolizumab (MK-3475...

Status

Completed

Location

Multiple Locations

Start Date

2014-08-25

Trial ID

NCT02142738

Treatments Being Tested

Pembrolizumab Paclitaxel Carboplatin Pemetrexed Cisplatin Gemcitabine

Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer

PHASE1

Dose-dense paclitaxel (Genexol®-PM) once a week in combination with carbopl...

Status

Unknown

Location

Samyang Biopharmaceuticals

Start Date

2016-04

Trial ID

NCT02739529

Treatments Being Tested

Genexol-PM

A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

PHASE3

This is a multicenter, multinational, double-blind, 1:1 randomized, paralle...

Status

Completed

Location

MedRadius

Start Date

2018-02-06

Trial ID

NCT03296163

Treatments Being Tested

MB02 (Bevacizumab Biosimilar Drug)EU-approved Avastin®Carboplatin Paclitaxel

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

PHASE3

Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...

Status

Active Not Recruiting

Location

Ironwood Cancer & Research Centers ( Site 0007)

Start Date

2020-12-08

Trial ID

NCT04624204

Treatments Being Tested

Pembrolizumab 200 mg Pembrolizumab 400 mg Pembrolizumab placebo (saline)Pembrolizumab placebo (saline)Olaparib 300 mg BID Olaparib matching placebo Etoposide 100 mg/m^2 Platinum, investigator's choice Standard Thoracic Radiotherapy Prophylactic Cranial Irradiation (PCI)

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

PHASE1

To find the best dose of ADI-PEG20 that can be given in combination with ca...

Status

Recruiting

Location

MD Anderson Cancer Center

Start Date

2024-02-29

Trial ID

NCT06085729

Treatments Being Tested

ADI-PEG 20 Cabazitaxel Carboplatin

Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

PHASE3

The purpose of this study is to explore if the combination of vinorelbine a...

Status

Completed

Location

Øystein Fløtten

Start Date

2007-09

Trial ID

NCT00737867

Treatments Being Tested

Vinorelbine Gemcitabine Vinorelbine Carboplatin

Previous Next